Skip to content
healthcare.dev

Senexon-S

NDC 0615-8331, Docusate Sodium 50mg and Sennosides 8.6mg, tablet, film coated, from NCS HealthCare of KY, LLC dba Vangard Labs.

Product NDC
0615-8331
Status
Listed
Labeler
NCS HealthCare of KY, LLC dba Vangard Labs
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH DRUG
Application
505G(a)(3)
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0615-8331 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • SENNOSIDES8.6 mg/1
  • DOCUSATE SODIUM50 mg/1
Package NDCNDC-11Package
0615-8331-050061583310515 TABLET, FILM COATED in 1 BLISTER PACK (0615-8331-05)
0615-8331-280061583312828 TABLET, FILM COATED in 1 BLISTER PACK (0615-8331-28)
0615-8331-390061583313930 TABLET, FILM COATED in 1 BLISTER PACK (0615-8331-39)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 0615-8331 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0615-8331 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0615-8331. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.